Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IonQ, Inc. (IONQ) has filed a Form 144 indicating an additional insider share sale. Peter Chapman intends to sell 1,497,311 shares of common stock through Merrill Lynch on or about 20 June 2025 on the NYSE. Based on the filing, IonQ has 261.6 million shares outstanding, so the proposed sale represents roughly 0.6 % of shares outstanding.
The filing also discloses that Chapman has already disposed of 4,491,933 shares in the past three months in two separate transactions dated 16 and 17 June 2025, generating US$171 million in gross proceeds. Taken together, recent and proposed sales total about 5.99 million shares, or ~2.3 % of outstanding stock.
All shares derive from stock-option exercises originally acquired on 17 Nov 2019. No material adverse, non-public information is acknowledged by the filer, and the sale may be conducted under a Rule 10b5-1 trading plan (date not provided). Apart from the sale notice, the document contains no operating metrics, earnings data, or strategic commentary.
Key datapoints
- Shares to be sold: 1,497,311
- Aggregate market value of proposed sale: US$59.7 million
- Broker: Merrill Lynch, San Francisco
- Issuer shares outstanding: 261.6 million
- Prior 3-month insider sales: 4.49 million shares for US$171 million
The elevated volume of insider selling, especially by a key executive, can signal reduced confidence or simple diversification; investors typically interpret sizeable Form 144 activity as a modest negative indicator unless offset by compelling corporate developments.
Item 5.07 – Results of IonQ’s 2025 Annual Meeting of Stockholders
IonQ, Inc. (NYSE: IONQ) reported the voting outcomes from its 17 June 2025 annual meeting. Two Class I directors were successfully re-elected to serve until the 2028 meeting: Niccolo de Masi received 60,572,382 “For” votes versus 1,986,960 withheld, while Inder M. Singh received 50,750,772 “For” votes versus 11,808,570 withheld. Each proposal carried 52,916,886 broker non-votes.
The non-binding “say-on-pay” proposal passed with 39,900,600 votes in favor (≈64 %), 22,233,654 against (≈35 %), and 425,088 abstentions, suggesting a material minority of shareholders question current compensation practices.
Shareholders overwhelmingly ratified Ernst & Young LLP as independent auditor for FY 2025, delivering 114,159,284 “For” votes (≈99 %), 588,969 against, and 727,975 abstentions.
No other matters were presented and the Form 8-K contained no financial performance updates, transactions, or strategic announcements.
IonQ director William F. Scannell received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Scannell now beneficially owns 140,560 shares directly.
Key details of the RSU grant:
- The RSUs were granted at $0 exercise price
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing represents standard equity compensation for board service, aligning the director's interests with shareholders through equity ownership. The transaction was executed under normal circumstances with no indication of unusual trading patterns.
IonQ director Gabrielle B. Toledano received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Toledano's direct ownership increased to 6,305 shares.
Key terms of the RSU award:
- Grant was made at $0 exercise price
- RSUs will vest in full at the earlier of:
- 2026 Annual Meeting (or day before if service ends at meeting)
- June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through stock ownership.
IonQ director Inder M. Singh received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Singh now beneficially owns a total of 32,603 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- The RSUs were granted at $0 exercise price
This Form 4 filing represents standard equity compensation for board service, aimed at aligning the director's interests with shareholders. The transaction was executed under normal circumstances with no indication of unusual trading patterns.
IonQ director Kathryn K. Chou received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Chou beneficially owns a total of 67,628 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - 2026 Annual Meeting (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- RSUs were granted at $0 exercise price
This Form 4 filing represents a standard director equity compensation grant, likely part of IonQ's annual board member compensation package. The transaction was executed under normal circumstances with no indication of any Rule 10b5-1 trading plan involvement.
IonQ Director Robert T. Cardillo received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Cardillo's direct ownership increased to 37,436 shares.
Key details of the RSU award:
- The RSUs were granted at $0 exercise price
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing, executed by Attorney-in-Fact Stacey Giamalis, represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through equity ownership.
IonQ Chief Financial Officer Thomas G. Kramer has executed a significant stock transaction on June 16, 2025, selling 216,000 shares of common stock at a weighted average price of $38.1131 per share. The transaction was conducted through a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025.
Following the transaction, Kramer retains direct ownership of 718,516 shares and indirect ownership of 5 shares through his child. The sales were executed at prices ranging from $36.07 to $39.14 per share.
Key transaction details:
- Transaction was executed pursuant to a Rule 10b5-1 plan, indicating pre-planned, scheduled trading activity
- Total transaction value approximately $8.23 million
- Significant retained ownership position indicates continued alignment with shareholder interests
- Filing was signed by attorney-in-fact Stacey Giamalis on June 18, 2025
IonQ Executive Chair Peter Chapman reported significant insider transactions executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025. The transactions occurred over two consecutive days:
- On June 16, 2025: Exercised 3,581,193 stock options at $0.1334 per share and subsequently sold them at an average price of $38.126
- On June 17, 2025: Exercised 910,740 stock options at $0.1334 per share and sold them at an average price of $37.7787
Following these transactions, Chapman retains 390,329 shares of common stock held directly and 1,604,972 vested stock options exercisable until May 16, 2029. The substantial price difference between the exercise price ($0.1334) and sale prices (>$36) resulted in significant gains. These pre-planned sales may indicate portfolio diversification rather than a lack of confidence in the company.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
